Pulmonary Hypertension Guide: Diagnosis and Home Care

Pulmonary hypertension is a progressive, often underdiagnosed condition in which blood pressure in the lungs’ arteries is abnormally high.

This guide explains what it is, how doctors confirm the diagnosis, practical steps for managing pulmonary hypertension at home, the role of breathing exercises, current pulmonary hypertension treatment options, and where the field is headed.

What pulmonary hypertension is and how it’s diagnosed

“Pulmonary hypertension” (PH) describes elevated pressure in the pulmonary circulation. It’s an umbrella term that includes five groups: pulmonary arterial hypertension (PAH), PH due to left heart disease, PH from chronic lung disease/hypoxia, chronic thromboembolic pulmonary hypertension (CTEPH), and PH with multifactorial/unclear mechanisms. Typical symptoms include breathlessness on exertion, fatigue, chest pressure, ankle swelling, palpitations, and, in advanced cases, lightheadedness or fainting.

Evaluation starts with a careful history and exam, blood tests (such as BNP/NT-proBNP), an electrocardiogram, chest imaging, pulmonary function testing, and a screening echocardiogram to estimate pulmonary pressures and right-heart size/function. A ventilation–perfusion (V/Q) scan helps detect chronic blood clots (CTEPH). Right heart catheterization is required to confirm the diagnosis and define the type of PH; current guidelines define PH as a mean pulmonary artery pressure (mPAP) above 20 mmHg at rest and use additional measurements to distinguish pre- vs. post-capillary disease. In selected patients with suspected PAH, vasoreactivity testing during catheterization identifies the small subset who may respond to high-dose calcium channel blockers.

Why breathing exercises matter for pulmonary hypertension

Breathing exercises are not a cure, and they do not reverse pulmonary hypertension, but they are a clinically supported tool for easing symptoms and improving day-to-day function.

When practiced safely, breathing exercises can:

support better oxygen exchange
reduce breathlessness by slowing and smoothing the breathing pattern
lower stress and heart rate during activity
improve posture and chest wall mechanics
enhance exercise tolerance when paired with supervised rehab

These benefits align with what pulmonary rehabilitation programs teach and are considered a helpful addition to standard medical care.

Breathing exercises and home strategies that help

Supervised, exercise-based rehabilitation programs for pulmonary hypertension can be safe and beneficial when tailored by clinicians familiar with PH. Under guidance, most patients do best with low-to-moderate intensity aerobic sessions (for example, interval walking or cycling 3–5 days/week) plus light resistance work and flexibility training. Multiple studies and international guidelines report improved exercise capacity, quality of life, and symptoms with structured programs.

Breathing techniques you can start gently

Pursed-lip breathing
Inhale through the nose for 2–3 seconds, then exhale through gently pursed lips for 4–6 seconds. This slows breathing, reduces air hunger, and helps control breathlessness during exertion.

Diaphragmatic (belly) breathing
Place one hand on the belly and one on the chest. Inhale slowly through the nose, letting the belly rise; exhale slowly through the mouth. Aim for 5–10 minutes, 1–2 times daily to strengthen the diaphragm and reduce shallow chest breathing.

Recovery breathing between intervals
After walking or climbing stairs, pause, lean slightly forward with hands on thighs, and use pursed-lip exhalation for 30–60 seconds to reset the breathing rhythm.

Additional techniques sometimes taught in pulmonary rehab include:

Box breathing (4-4-4-4)
A gentle relaxation cycle—inhale four seconds, hold four, exhale four, pause four. Useful for lowering stress and heart rate.

Segmental breathing
A therapist-guided technique that directs air into specific lung regions through cueing or gentle pressure. Best done under supervised rehab.

Inspiratory muscle training (IMT)
Uses a handheld resistance device to strengthen breathing muscles. Studies suggest improved exercise capacity when done with professional oversight.

Gentle yoga-based breathing
Slow, relaxed patterns (no long breath-holds) can reduce tension. Always confirm with your PH team before adding new practices.

Safe activity and pacing

Interval over continuous: 1–3 minutes of activity followed by 1–2 minutes of rest is often more comfortable.
Use symptoms and oximetry: Keep a conversational pace; use supplemental oxygen as prescribed.
Avoid strain and Valsalva: Lift lighter weights, use steady exhalation during effort.
Progress gradually: Increase total weekly activity by only 5–10%.

Daily self-care that supports the lungs and heart

Fluid and salt awareness: Track sodium intake; monitor weight for early signs of fluid retention.
Sleep and breathing: Treat sleep apnea when present (e.g., CPAP).
Vaccinations: Stay current on influenza, COVID-19, and pneumococcal vaccines.
Environment: Avoid high altitude without medical advice; plan breaks during activity and travel.
Smoking: Avoid smoking and secondhand smoke, which worsen pulmonary vascular injury.

These strategies support symptom control and stamina, but they do not replace individualized medical care.

Can pulmonary hypertension be reversed?

Most forms of pulmonary hypertension cannot be fully reversed, but many can be slowed, stabilized, or partially improved depending on the cause.

What helps:

Targeted medications: ERAs, PDE5 inhibitors, prostacyclins, and riociguat reduce vascular resistance and improve right-heart function.
Oxygen therapy: Supports patients with low saturations.
Lifestyle adjustments: Low-salt diet, no smoking, supervised activity.
Procedures when indicated: Pulmonary endarterectomy or balloon pulmonary angioplasty for chronic thromboembolic disease; atrial septostomy or lung transplantation in advanced cases.

For some causes (for example, cured chronic clots after pulmonary endarterectomy), PH can improve significantly. But for most, treatment focuses on control—not cure.

A sample day of breathing support might include:

Morning: 5 minutes diaphragmatic breathing
Afternoon: A few cycles of box breathing
During activity: Pursed-lip breathing on hills or stairs
Evening: Gentle relaxation breathing

Always start short and progress only with medical guidance.

Current medical treatments

Modern care is guided by risk stratification (low, intermediate, high) and the underlying cause. For PAH and some other forms, the main medicines for pulmonary hypertension target three pathways that relax or remodel the pulmonary arteries and improve right-heart function:

Endothelin pathway (ERAs): ambrisentan, bosentan, macitentan
Nitric oxide–cGMP pathway: sildenafil, tadalafil, and the sGC stimulator riociguat (PDE5 inhibitors must not be combined with riociguat)
Prostacyclin pathway: IV epoprostenol; treprostinil (IV/subcutaneous/inhaled/oral); iloprost; selexipag (oral IP receptor agonist)

Initial combination therapy is now standard for many newly diagnosed PAH patients. Those who remain intermediate- or high-risk escalate to additional oral agents or parenteral prostacyclins. A very small subset with positive vasoreactivity testing is treated with high-dose calcium channel blockers.

Beyond PAH, treatment targets the cause:

Left-heart disease: optimize heart failure care
Lung disease/hypoxia: treat the lung condition; use oxygen as needed
CTEPH: lifelong anticoagulation, pulmonary endarterectomy when possible, and balloon pulmonary angioplasty when surgery isn’t feasible

Diuretics, iron repletion, and pregnancy counseling are used across groups based on individual need.

The future of treatment

A major advance is sotatercept, the first activin-signaling inhibitor approved in 2024 for adults with PAH. Added to background therapy, it improves exercise capacity and hemodynamics and represents a shift toward therapies that address disease remodeling, not just vasodilation.

Other promising areas include:

inhaled tyrosine kinase inhibitors (e.g., imatinib formulations, seralutinib)
improved balloon pulmonary angioplasty for CTEPH
pulmonary artery denervation
genetic and molecular profiling to personalize therapy
wearable sensors and remote monitoring to track symptoms and trends

While we still don’t have a universal answer for how to reverse pulmonary hypertension, these innovations aim to slow progression and meaningfully improve outcomes.